MANNKIND CORP·4

Jan 31, 6:12 PM ET

Kendall David M 4

4 · MANNKIND CORP · Filed Jan 31, 2019

Insider Transaction Report

Form 4
Period: 2019-01-31
Kendall David M
Chief Medical Officer
Transactions
  • Purchase

    Common Stock, $0.01 Par Value

    2019-01-31$1.07/sh+5,000$5,3507,824 total
Footnotes (1)
  • [F1]The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2019 representing the maximum allowable under the Plan for this period.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION